ID: ALA5306174

Max Phase: Preclinical

Molecular Formula: C24H32O4

Molecular Weight: 384.52

Associated Items:

Representations

Canonical SMILES:  C#CC1CC2C3CCC4=CC(OC(C)=O)CCC4C3CCC2(C)C1OC(C)=O

Standard InChI:  InChI=1S/C24H32O4/c1-5-16-13-22-21-8-6-17-12-18(27-14(2)25)7-9-19(17)20(21)10-11-24(22,4)23(16)28-15(3)26/h1,12,16,18-23H,6-11,13H2,2-4H3

Standard InChI Key:  BVXLMMNMQUPTKS-UHFFFAOYSA-N

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 384.52Molecular Weight (Monoisotopic): 384.2301AlogP: 4.28#Rotatable Bonds: 2
Polar Surface Area: 52.60Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.54CX LogD: 3.54
Aromatic Rings: 0Heavy Atoms: 28QED Weighted: 0.41Np Likeness Score: 2.04

References

1. Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL..  (2019)  Mapping human microbiome drug metabolism by gut bacteria and their genes.,  570  (7762): [PMID:31158845] [10.1038/s41586-019-1291-3]